AVMBioMed is a contract research organization (CRO) specializing in the novel discovery of post-translational modifications (PTM). Our Snapshot Proteomics™ technology uses protein microarrays to capture PTM from complex mixtures like cell extracts and patient samples, identifies specific protein-protein interactions, and reveals novel enzyme-substrate pairings across 20,000 human proteins. Our services provide powerful and novel information for basic science, target validation, preclinical compound characterization and biomarker discovery.
